Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Mapreg, explained in plain language.
This phase 2 study tested a daily oral drug called MAP4343 in 126 adults whose depression did not improve with standard antidepressants. Participants took either MAP4343 or a placebo for 6 weeks. The main goal was to see if the drug reduced depression symptoms more than placebo, …
Phase 2 • Sponsor: Mapreg • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC